Biomedical Engineering Reference
In-Depth Information
80. Hof man, T.J., G.L. Sieckman, W.A. Volkert, and H.S. Truman, Iodinated
bombesin analogues: Ef ect of N-terminal vs side chain iodine attachment
on BBN/GRP receptor binding.
Journal of Nuclear Medicine
, 1996. 37(5): p.
850.
81. Hof man, T.J., T.P. Quinn, and W.A. Volkert, Radiometallated receptor-avid
peptide conjugates for specii c in vivo targeting of cancer cells.
Nucl Med
Biol,
2001. 28(5): p. 527.
82. Karra, S.R., R. Schibli, H. Gali, K.V. Katti, T.J. Hof man, C. Higginbotham,
G.L. Sieckman, and W.A. Volkert, 99mTc-labeling and in vivo studies of a
bombesin analogue with a novel water-soluble dithiadiphosphine-based
bifunctional chelating agent.
Bioconjug Chem
, 1999. 10(2): p. 254.
83. Hu, F., C.S. Cutler, T. Hof man, G. Sieckman, W.A. Volkert, and S.S. Jurisson,
Pm-149 DOTA bombesin analogs for potential radiotherapy - In vivo com-
parison with Sm-153 and Lu-177 labeled DO3A-amide-beta Ala-BBN(7-14)
NH2.
Nuclear Medicine and Biology
, 2002. 29(4): p. 423.
84. Saurin, J.C., J.P. Rouault, J. Abello, F. Berger, L. Remy, and J.A. Chayvialle,
High gastrin releasing peptide receptor mRNA level is related to tumour
dedif erentiation and lymphatic vessel invasion in human colon cancer.
Eur
J Cancer
, 1999. 35(1): p. 125.
85. Tang, C., I. Biemond, G.J. Of erhaus, W. Verspaget, and C.B. Lamers,
Expression of receptors for gut peptides in human pancreatic adenocarci-
noma and tumour-free pancreas.
Br J Cancer
, 1997. 75(10): p. 1467.
86. Scott, N., E. Millward, E.J. Cartwright, S.R. Preston, and P.L. Coletta, Gastrin
releasing peptide and gastrin releasing peptide receptor expression in gastro-
intestinal carcinoid tumours.
J Clin Pathol
, 2004. 57(2): p. 189.
87. Toi-Scott, M., C.L. Jones, and M.A. Kane, Clinical correlates of bombesin-
like peptide receptor subtype expression in human lung cancer cells.
Lung
Cancer,
1996
.
15(3): p. 341.
88. Reubi, J.C., S. Wenger, J. Schmuckli-Maurer, J.C. Schaer, and M. Gugger,
Bombesin receptor subtypes in human cancers: detection with the universal
radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombe-
sin(6-14).
Clin Cancer Res
, 2002. 8(4): p. 1139.
89. Preston, S.R., L.F. Woodhouse, S. Jones-Blackett, J.I. Wyatt, and J.N. Primrose,
High ai nity binding sites for gastrin releasing peptide on human gastric
cancer and Menetrier's mucosa.
Cancer Res
, 1993. 53(21): p. 5090.
90. Markwalder, R. and J.C. Reubi, Gastrin-releasing peptide receptors in the
human prostate: relation to neoplastic transformation.
Cancer Res
, 1999.
59(5): p. 1152.
91. Chave, H.S., A.C. Gough, K. Palmer, S.R. Preston, and J.N. Primrose,
Bombesin family receptor and ligand gene expression in human colorectal
cancer and normal mucosa.
Br J Cancer
, 2000. 82(1): p. 124.
92. Patel, O., A. Shulkes, and G.S. Baldwin, Gastrin-releasing peptide and can-
cer.
Biochim Biophys Acta
, 2006.
